Genentech

Roche Breast Cancer Prospect Fails First-Line Test, Shares Fall

After Exiting 2seventy, Chip Baird Took a 180 to Food Allergy With Newly Launched Poplar

Sangamo Therapeutics Inc (SGMO) Q1 2026 Earnings Call Transcript

Burnout Common but Regrets Are Not in Allergy, Immunology

The 5 Largest IPOs in Biopharma History

Roche Raises NC Manufacturing Investment to $2B To Support Obesity Challenge

Analysis Finds Efficiencies, Savings of Using a Single Bispecific for DLBCL and FL

AI Pioneers Unite to Launch the Shared AI License Foundation to Advance Foundation Model Innovation

Lost in Translation: Cancer Care’s Growing Health Literacy Crisis

Trump’s New Drug Advertising Proposals Fall Short on Public Health and the Constitution

American Assets Trust Q1 2026 FFO Rises to $0.51 as Office Leasing Remains Strong

Why Owning the Learning Loop Matters More Than Owning the Lab

Ocrelizumab Preserves Ambulation, Hand Function in MS

JPM Recap; Mirador Raises $250M; Genentech’s PBM Shift; and More

AI Giant Anthropic Leans Into Life Sciences With $400M Coefficient Bio Catch

AbbVie Opts for North Carolina to House $1.4bn Manufacturing Site

What Does 17 Pharma MFN Deals Are Underneath the Press Releases: The Real Primary Source Stack, the GLP1 Numbers, TrumpRX Plumbing, and Where the New Adjudication Layer Gets Monetized

The Stanford Professor Behind an FDA-Cleared Cardiac AI Wants $1 Billion for His Next Company

FDA Clears Genentech’s Tecentriq for ctDNA-Guided Adjuvant Bladder Cancer Therapy

Seven Biotech Companies to Know in the Netherlands 

FDA Approves Ocrevus for Children 10+ with Relapsing‑Remitting MS

IAM1363

AbbVie Commits $1.4B to NC Plant in Its Largest-Ever Single Campus Investment

Claritas Rx Appoints New CRO and Promotes Two VPs to Accelerate Growth

Gene Therapy Reduces Geographic Atrophy Lesion Growth

Early Intervention an Unmet Need in Diabetic Macular Edema

Biogen’s Alzheimer’s Results Bolster Tau Theory—And Denali’s Next Gen Candidate

FDA Clears Genentech’s Ocrevus for Pediatric Relapsing‑Remitting MS

Storm Therapeutics Secures $56M to Advance Cancer Drugs

Parkinson’s Awareness Month and World Parkinson’s Day 2026: Advocacy and Therapeutic Progress

Fenebrutinib (GDC-0853)

Combination of Ranibizumab, Dexamethasone Superior to Ranibizumab Alone for Macular Edema

Whole-Food Plant-Based Diet Aids Men with Prostate Cancer

Roche Boosts NC Factory Investment to $2B; Rentschler CEO Steps Down

First Bispecific-ADC Combo Shows Strong Results in R/R Mantle Cell Lymphoma

Gut Microbe May Be Linked to Lupus Pathogenesis

Genentech Secures FDA Approval for Tecentriq in Muscle‑Invasive Bladder Cancer

Natera’s Solomon Moshkevich on How MRD Testing Pinpoints Cancer Recurrence

AbbVie (ABBV) Is One Of The Major Stock To Buy According To Wall Street

FDA Approves Atezolizumab for Adjuvant Treatment of Muscle Invasive Bladder Cancer in Patients with Molecular Residual Disease

Teva Intensifies Biosimilar Competition with FDA Approval and Dual Filing Acceptance in US and Europe

GSK Reaches $2.2bn Deal to Buy Food Allergy Biotech RAPT

Genentech CEO Says Pharmacy Benefit Manager Shift Will Save $70M

Genentech, SanegeneBio Launch Up-to-$1.7B RNAi Collaboration

Once More Into the Valley of Death: Navigating SBIR/STTR Funding for Tech Startups After 2025

FDA Approves Ocrevus for Relapsing-Remitting MS in Children Aged 10 Years and Up

Genentech Partners With Comedy Icon Damon Wayans and diaTribe to Address Diabetes-Related Vision Loss With ‘All Eyes on DME’ Campaign

JPM Lineup: New Roles Across Industry

‘Orchestra of Therapies’ Required for Most SSc Patients

Bring on the Breakthroughs: ASCO Takes Translation to More Patients